Supplementary experimental procedures
Cell culture and survival assays
XPV cells complemented with Pol!-GFP were kindly provided by Dr. E.A. Drobetsky.
XPV cells were maintained in DMEM supplemented with 15 % Fetal Bovine Serum and 1 % penicillin/streptomycin.
For survival assays 80-90%-confluent 10cm plates of XPV cells complemented with εGFP or Pol!-εGFP, were washed once and covered with 10 ml of PBS. Cells were then exposed to increasing dose of UV (1,2,3,4 or 5 J/m 2 ) using a UVC500/UV Crosslinker (Hoefer), harvested immediately and counted. 5000 cells/well were plated in 96-wells plate and allowed to grow at 37°C, 5% CO2, in dark for 50 hours. MTT assay was performed using the MTT Cell Proliferation Assay kit of ATCC bioproducts.
Antibodies
Commercial antibodies used were anti-PALB2 polyclonal antibody (Bethyl), anti-PALB2 polyclonal antibody (Novus), anti-BRCA2 monoclonal antibody (OP95, Calbiochem), anti-POLH monoclonal antibody (Santa Cruz, B-7) and anti-POLH polyclonal antibody (Santa Cruz and Bethyl), anti-RAD51 monoclonal antibody (14B4, Novus), anti-RAD51 polyclonal antibody (Santa Cruz), anti-RPA polyclonal antibody (Bethyl), anti-Histidine (Clontech), anti-Flag monoclonal antibody (Sigma), anti-PCNA monoclonal antibody (PC10, Santa-Cruz), anti-gamma H2AX (Cell signaling). The rabbit polyclonal anti-GST antibody was generated by immunizing rabbits with recombinant GST which was purified from Escherichia coli. For immunofluorescence, rabbit polyclonal anti-PALB2
antibody was generated by immunizing rabbits as previously described (Xia et al., 2006) .
Immunofluorescence studies
XPV cells complemented with Pol!-GFP treated with 2 mM of HU or 1 µg/ml of aphidicolin for 16-18 h, were fixed with 2% paraformaldehyde in PBS for 10 min, washed with TBS and fixed with cold methanol (-20°C) for 5 min. Next, cells were permeabilized with PBS containing 0.2% Triton X-100 for 5 min and washed three times 5 min with TBS. Then, cells were quenched with 0.1% Sodium Borohydride for 5 min, washed once with TBS, blocked in PBS containing 10% goat serum and 1% BSA for 1 h and incubated with the primary antibody diluted in PBS 1% BSA for 2 h at room temperature. Coverslips were washed three times for 10 min with TBS before 1 h incubation with the appropriate secondary antibody conjugated to a fluorophore. Cells were rinsed again three times for 10 min with TBS. Coverslips were mounted onto slides with PBS-glycerol (90%) containing 1 mg/ml paraphenylenediamine and 0.2 mg/ml of 4, 6-diamidino-2-phenylindole (DAPI). Immunofluorescence with PCNA antibody was performed as described (Kannouche et al., 2001 ).
To monitor RAD51 foci formation, the following protocol was used. XPV cells complemented with Pol!-"GFP (either untreated or treated with 2 mM of HU for 16-18 h) were plated on poly-L-lysine treated glass coverslips. Cells were fixed with 2% paraformaldehyde in PBS for 10 min, washed with TBS and fixed with cold methanol 
Purification of GST-fusions
Protein truncations fused to GST were purified from 1 liter of BL21(DE3) RP (Stratagene), grown at 37°C in Luria broth medium supplemented with 100 µg/ml ampicillin, and 25 µg/mL chloramphenicol. At OD600 = 0.4 , 0.1 mM IPTG was added to the culture and incubated at 15°C overnight for 16 hours. Cells were centrifuged (5000 rpm, 15 minutes) and the cell pellet was resuspended in 40 mL of GST buffer (10 mM Na 2 HPO4, 2 mM KH 2 PO 4 , 297 mM NaCl, 2.7 mM KCl, 1 mM EDTA and 1 mM DTT) containing protease inhibitors (Roche). The suspension was lysed using a Dounce homogenizer (10 strokes), sonicated three times 30 seconds (50% output), and then homogenized a second time. Insoluble material was removed by centrifugation (35,000 rpm for 40 minutes). 2 ml of Glutathione Sepharose (GE Healthcare) was added to the supernatant and incubated for 2 hours at 4°C. Then, beads were washed three times with GST washing buffer (10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , 500 mM NaCl, 2,7 mM KCl, 1 mM EDTA and 1 mM DTT) and incubated 30 min in GST washing buffer supplemented with 5mM ATP and 15 mM MgCl 2 . Proteins were eluted with GST buffer containing 25 mM Glutathione, and dialysed in storage buffer (20 mM Tris-Acetate, pH 8.0, 200 mM KOAc, 1 mM EDTA, 0.5 mM DTT and 10% glycerol) and stored at -80°C.
Co-immunoprecipitations and GST pull-downs
XPV cells complemented with Pol!-GFP were resuspended in lysis buffer (50 mM TrisHCl, pH 7.5, 150mM NaCl, 0.5 % NP-40) containing protease and phosphatase inhibitors 4 (PMSF (1 mM), aprotinin (0.019 TIU/mL), leupeptin (1 µg/ml), NaF (5 mM) and Na3VO4 (1 mM)). Cells were then incubated for 30 min on ice and lysed by sonication (two times 10 seconds, 50% output). Insoluble material was removed by high-speed centrifugation (14 000 rpm, 30 min at 4°C) and each immunoprecipitation was carried out using soluble protein extract (3000 mg) in 1 ml lysis buffer. The samples were first incubated for 1.5 hour at 4°C with the indicated antibodies. Protein complexes were then pulled down with 20 µL of protein A/G sepharose beads (Pierce) for an hour.
Immunoprecipitates were washed four times in lysis buffer and visualized by Western blotting using the indicated antibodies.
Immunoprecipitation from purified proteins were performed as follows. Purified PALB2 or BRCA2 and Pol! were incubated in 100 µl of IPR buffer 20 mM Tris-Acetate pH 8.0, 125 mM KOAc, 0.5 mM EDTA, 0.5% NP40, 10% glycerol, 0.1 mg/ml BSA, 1mM
DTT for 30 minutes at 37°C. 1 µg antibodies were added for 1 hour at 4°C followed by the addition of protein A/G sepharose beads (Pierce) for 20 minutes.
Immunoprecipitates were washed four times in IPR buffer and visualized by Western blotting using the indicated antibodies.
GST-pulldown assays using 1 µg GST alone or GST-truncations (250 ng) were performed in 500 µL of GSTB buffer (20 mM KPO4 pH 7.4, 0.5 mM EDTA, 10% glycerol, 0.5% NP40, 1 mM DTT, 200 mM KCl, 1 mg/ml BSA). GST or GST-truncations were incubated with Pol! (250 ng) for 30 min at room temperature and Glutathione Sepharose beads (GE Healthcare) were added for 20 minutes. Complexes were washed four times with GSTB buffer without BSA. Proteins were visualized by Western blotting using the indicated antibodies.
Co-immunoprecipitation of Pol! with PALB2 was performed from baculovirus-infected cells. Briefly, Sf9 cells were co-infected with PALB2-GST-His or PALB2-Q775X-GST-His with Pol! baculovirus. 48 hrs post-infection, cells were harvested for immunoprecipitation and lysed by sonication in 1ml of GST lysis buffer (250 mM NaCl, 1 mM EDTA, 0.05% Triton X-100, 1mM DTT in PBS1X supplemented with protease inhibitors). Insoluble material was cleared by high-speed centrifugation. Prewashed GST beads were incubated with .1mg/ml BSA for 1 hr at 4°C and then the soluble lysate was incubated with pre-coated GST beads for 1 hr at 4°C. Complexes were washed 4 times with GST lysis buffer and visualized by Western blotting by using anti-histidine monoclonal or Pol! polyclonal antibody.
Immunoprecipitation from endogenous proteins were performed as follows. U2OS cells, untreated or treated with 2mM of HU for 18h, were lysed in IP150 buffer (50mM TrisHCl pH 7.4, 150mM NaCl, 0,5% NP40 supplemented with PMSF, aprotinin, leupeptin, NaF (5mM) and Na 3 VO 4 1mM) for 30 min on ice followed by 3x10sec of sonication (40% output). Cell extracts were then incubated for 6 hours at 4°C, respectively, with anti-polη antibody (Bethyl, PolH Antibody), followed by the addition of protein A/G sepharose beads (Pierce) for 45 minutes. Immunoprecipitates were washed four times in IP150
buffer, eluted in Laemmli buffer 2X and visualized by Western blotting using the indicated antibodies.
DNA binding assays
Reactions (10 µl) contained 32 P-labelled DNA oligonucleotides (25 nM in nucleotides of each substrate) and PALB2 or PALB2 Q775X were incubated in binding buffer (10 mM TrisHCl pH 7.9, 60 mM KOAc, 1 mM DTT and 100 µg.mL -1 BSA). Reaction mixtures were incubated at 37°C for 15 minutes, followed by 15 minutes of fixation in 0.2% glutaraldehyde. Reactions were analyzed by electrophoresis through a 8% TBE1X/acrylamide gel, run at 150V, dried onto DE81 filter paper, and visualized by autoradiography.
Exonuclease III protection
Reactions (10 µl) containing 32 P-labelled synthetic D-loop (500 nM) were incubated with indicated proteins in buffer containing 10 mM Tris-HCl pH 7.9, 60 mM KOAc, 0.7 mM MgCl 2 , 100 nM dNTP, 1 mM DTT and 100 µg/ml BSA for 5 min at 37°C following by addition of exonuclease III (50 µU, NEB). After 20 min incubation at 37°C, reactions were deproteinized with proteinase K (2 µg/µl) for 20 min at 37°C. Formamide was added to a final concentration of 60% (v/v) and the samples loaded on a 8% denaturing 6 acrylamide (7M Urea), 1X TBE gel, runned at 75W, dried and visualized by autoradiography. Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., DNA synthesis products were analyzed by denaturing PAGE.
α-BRCA2 (endo) I n p u t I P I g G I P P o l η I n p u t I P I g G I P P o l η and Polη, as shown in Figure 6B . (J) Puri ed D-loop substrate was incubated with increasing concentrations of puri ed piBRCA2 or piBRCA2
followed by an addition of Polη. DNA synthesis products were analyzed by alkaline gel electrophoresis. were subjected for immuno uorescence against Polη (green) or anti-Flag antibodies to discriminate transfected cells. siRNA BRCA2 resistant constructs were used.
